Table of Content


Introduction
sopharyngeal Cancer - Overview
sopharyngeal Cancer - Therapeutics Development
sopharyngeal Cancer - Therapeutics Assessment
sopharyngeal Cancer - Companies Involved in Therapeutics Development
sopharyngeal Cancer - Drug Profiles
sopharyngeal Cancer - Dormant Projects
sopharyngeal Cancer - Discontinued Products
sopharyngeal Cancer - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Nasopharyngeal Cancer, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Top 10 Routes of Administration, H2 2020
Number of Products by Stage and Top 10 Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Nasopharyngeal Cancer, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Nasopharyngeal Cancer - Pipeline by Advenchen Laboratories LLC, H2 2020
Nasopharyngeal Cancer - Pipeline by Akeso Inc, H2 2020
Nasopharyngeal Cancer - Pipeline by Alphamab Oncology, H2 2020
Nasopharyngeal Cancer - Pipeline by Ambrx Inc, H2 2020
Nasopharyngeal Cancer - Dormant Projects, H2 2020
Nasopharyngeal Cancer - Discontinued Products, H2 2020